Media Summary: Speakers: Klaus Romero (C-Path) and Ed Neilan (NORD) Subscribe to C-Path Now ... Featured speakers and panelists will provide Patient, Industry and Regulatory perspectives on clinical trial endpoints, modeling ... Keynote Speaker: Theresa Mullin (FDA/CDER) Subscribe to C-Path Now ▻▻

2022 Rdca Dap Workshop Future - Detailed Analysis & Overview

Speakers: Klaus Romero (C-Path) and Ed Neilan (NORD) Subscribe to C-Path Now ... Featured speakers and panelists will provide Patient, Industry and Regulatory perspectives on clinical trial endpoints, modeling ... Keynote Speaker: Theresa Mullin (FDA/CDER) Subscribe to C-Path Now ▻▻ Centrality of Patient Advocacy Organizations in Accelerating Treatments for Rare Disease Speakers: Aliza Fink (NORD) and Ed ... Rare Disease (RD) Consortia - Duchenne Regulatory Science Consortia (D-RSC): Presentation on modeling work surrounding ... This webinar session will present an overview of the

Webinar Presented on June 24, 2020. The National Organization for Rare Disorders (NORDR), Critical Path Institute (C-Path), ... Rare Disease (RD) Consortia - Critical Path for Sickle Cell Disease Consortium (CP-SCD): Presentation on how This video provides insight on how the Rare Disease Cures Accelerator-Data and Analytics Platform ( Data Sharing and Analysis to Support Rare Disease Drug Development The European infrastructure for translational medicine, ... The brief demonstration provides an overview of Critical Path Institute's Rare Disease Cures Accelerator-Data and Analytics ...

Photo Gallery

2022 RDCA-DAP Workshop:  Future of RDCA-DAP and the Patient Voice
2022 RDCA-DAP Workshop: Opening Remarks
2022 RDCA-DAP Workshop: Case Studies Panel Discussion and Q&A
2022 RDCA-DAP Workshop: Keynote
2022 RDCA-DAP Workshop: Centrality of Patient Advocacy Organizations in Accelerating Treatments
2022 RDCA-DAP Workshop: Case Study 3, Duchenne Regulatory Science Consortia (D-RSC)
Sharing Data With RDCA-DAP: Your Questions Answered
From Vision to Reality: 6 Years of RDCA-DAP, Driving Drug Development Solutions
Shortening the Timeline for Developing New Treatments - How the RDCA-DAP Can Help
2022 RDCA-DAP Workshop: Case Study 2, Critical Path for Sickle Cell Disease Consortium (CP-SCD)
How Will RDCA-DAP® Support Patient-Focused Drug Development?
Webinar: RDCA-DAP and EATRIS Present Rare Disease Drug Development
View Detailed Profile
2022 RDCA-DAP Workshop:  Future of RDCA-DAP and the Patient Voice

2022 RDCA-DAP Workshop: Future of RDCA-DAP and the Patient Voice

Presentation(s)/Discussion on

2022 RDCA-DAP Workshop: Opening Remarks

2022 RDCA-DAP Workshop: Opening Remarks

Speakers: Klaus Romero (C-Path) and Ed Neilan (NORD) Subscribe to C-Path Now ...

2022 RDCA-DAP Workshop: Case Studies Panel Discussion and Q&A

2022 RDCA-DAP Workshop: Case Studies Panel Discussion and Q&A

Featured speakers and panelists will provide Patient, Industry and Regulatory perspectives on clinical trial endpoints, modeling ...

2022 RDCA-DAP Workshop: Keynote

2022 RDCA-DAP Workshop: Keynote

Keynote Speaker: Theresa Mullin (FDA/CDER) Subscribe to C-Path Now ▻▻ https://www.youtube.com/c/CriticalPathInstitute ...

2022 RDCA-DAP Workshop: Centrality of Patient Advocacy Organizations in Accelerating Treatments

2022 RDCA-DAP Workshop: Centrality of Patient Advocacy Organizations in Accelerating Treatments

Centrality of Patient Advocacy Organizations in Accelerating Treatments for Rare Disease Speakers: Aliza Fink (NORD) and Ed ...

2022 RDCA-DAP Workshop: Case Study 3, Duchenne Regulatory Science Consortia (D-RSC)

2022 RDCA-DAP Workshop: Case Study 3, Duchenne Regulatory Science Consortia (D-RSC)

Rare Disease (RD) Consortia - Duchenne Regulatory Science Consortia (D-RSC): Presentation on modeling work surrounding ...

Sharing Data With RDCA-DAP: Your Questions Answered

Sharing Data With RDCA-DAP: Your Questions Answered

Learn more: https://rarediseases.org/

From Vision to Reality: 6 Years of RDCA-DAP, Driving Drug Development Solutions

From Vision to Reality: 6 Years of RDCA-DAP, Driving Drug Development Solutions

This webinar session will present an overview of the

Shortening the Timeline for Developing New Treatments - How the RDCA-DAP Can Help

Shortening the Timeline for Developing New Treatments - How the RDCA-DAP Can Help

Webinar Presented on June 24, 2020. The National Organization for Rare Disorders (NORDR), Critical Path Institute (C-Path), ...

2022 RDCA-DAP Workshop: Case Study 2, Critical Path for Sickle Cell Disease Consortium (CP-SCD)

2022 RDCA-DAP Workshop: Case Study 2, Critical Path for Sickle Cell Disease Consortium (CP-SCD)

Rare Disease (RD) Consortia - Critical Path for Sickle Cell Disease Consortium (CP-SCD): Presentation on how

How Will RDCA-DAP® Support Patient-Focused Drug Development?

How Will RDCA-DAP® Support Patient-Focused Drug Development?

This video provides insight on how the Rare Disease Cures Accelerator-Data and Analytics Platform (

Webinar: RDCA-DAP and EATRIS Present Rare Disease Drug Development

Webinar: RDCA-DAP and EATRIS Present Rare Disease Drug Development

Data Sharing and Analysis to Support Rare Disease Drug Development The European infrastructure for translational medicine, ...

RDCA-DAP Demonstration

RDCA-DAP Demonstration

The brief demonstration provides an overview of Critical Path Institute's Rare Disease Cures Accelerator-Data and Analytics ...